File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
  • Find via Find It@HKUL
Supplementary

Conference Paper: Association of novel single-nucleotide polymorphisms in the dihydropyridine sensitive L-type Alpha-3 Calcium Channel (CACNL1 α 3) and Thyrotoxic Periodic Paralysis (TPP)

TitleAssociation of novel single-nucleotide polymorphisms in the dihydropyridine sensitive L-type Alpha-3 Calcium Channel (CACNL1 α 3) and Thyrotoxic Periodic Paralysis (TPP)
Other TitlesAssociation of novel single-nucleotide polymorphisms in the dihydropyridine sensitive L-type alpha-3 calcium channel (CACNL1 alpha 3) and thyrotoxic periodic paralysis (TPP)
Authors
Issue Date2003
PublisherMary Ann Liebert, Inc Publishers. The Journal's web site is located at http://www.liebertpub.com/thy
Citation
The 75th Annual Meeting of the American Thyroid Association (ATA 2003), Palm Beach, FL., 17-21 September 2003. In Thyroid, 2003, v. 13 n. 7, p. 672, program no. 6 How to Cite?
AbstractTPP is a frequent complication of thyrotoxicosis occurring sporadically among southern Chinese men. Intracellular shift of potassium results in hypokalaemia and acute muscle paralysis. The clinical presentation of TPP is very similar to an autosomal dominantly inherited disease familial hypokalaemic periodic paralysis (FHPP), which is not associated with thyrotoxicosis. FHPP is associated predominantly with mutations in the dihydropyridine receptor gene, which encodes a subunit of calcium channel in muscle (CACNL1a3), and in a few cases mutations involving the sodium channel (SCN4A) or potassium channel (KCNE3). To study whether there are similar mutations occurring among the TPP subjects, we directly sequenced the 44 exons of the candidate gene for mutations in 97 male TPP patients, 77 patients with Graves’ disease (GD) but no TPP and 100 normal male subjects. We also studied the microsatellite markers in chromosome 1 in the region of the Na/K-ATPase subunit a1, a2, and b1. Results showed that none of the TPP patients carried the known mutations in the CACNL1a3, SCN4A and KCNE3 gene. There was no association of TPP with the microsatellite markers that mapped to 1p13, 1q21-23, 1q22-25 and 1q31-32. We detected 12 single nucleotide polymorphisms (SNPs) in the CACNL1a3 in our population, of which 4 were novel. An A/G polymorphism in intron 26 was significantly associated with TPP as compared to GD and normal controls (p , 0.001). The identification of the associated SNPs may enable detection of carriers who may be predisposed to TPP.
DescriptionProgram no. 6: Thyroid Diseases - Wednesday - Clinical Oral
Persistent Identifierhttp://hdl.handle.net/10722/102590
ISSN
2015 Impact Factor: 3.784
2015 SCImago Journal Rankings: 1.458

 

DC FieldValueLanguage
dc.contributor.authorKung, AWC-
dc.contributor.authorLau, KS-
dc.contributor.authorFong, GCY-
dc.contributor.authorChan, VNY-
dc.date.accessioned2010-09-25T20:36:47Z-
dc.date.available2010-09-25T20:36:47Z-
dc.date.issued2003-
dc.identifier.citationThe 75th Annual Meeting of the American Thyroid Association (ATA 2003), Palm Beach, FL., 17-21 September 2003. In Thyroid, 2003, v. 13 n. 7, p. 672, program no. 6-
dc.identifier.issn1050-7256-
dc.identifier.urihttp://hdl.handle.net/10722/102590-
dc.descriptionProgram no. 6: Thyroid Diseases - Wednesday - Clinical Oral-
dc.description.abstractTPP is a frequent complication of thyrotoxicosis occurring sporadically among southern Chinese men. Intracellular shift of potassium results in hypokalaemia and acute muscle paralysis. The clinical presentation of TPP is very similar to an autosomal dominantly inherited disease familial hypokalaemic periodic paralysis (FHPP), which is not associated with thyrotoxicosis. FHPP is associated predominantly with mutations in the dihydropyridine receptor gene, which encodes a subunit of calcium channel in muscle (CACNL1a3), and in a few cases mutations involving the sodium channel (SCN4A) or potassium channel (KCNE3). To study whether there are similar mutations occurring among the TPP subjects, we directly sequenced the 44 exons of the candidate gene for mutations in 97 male TPP patients, 77 patients with Graves’ disease (GD) but no TPP and 100 normal male subjects. We also studied the microsatellite markers in chromosome 1 in the region of the Na/K-ATPase subunit a1, a2, and b1. Results showed that none of the TPP patients carried the known mutations in the CACNL1a3, SCN4A and KCNE3 gene. There was no association of TPP with the microsatellite markers that mapped to 1p13, 1q21-23, 1q22-25 and 1q31-32. We detected 12 single nucleotide polymorphisms (SNPs) in the CACNL1a3 in our population, of which 4 were novel. An A/G polymorphism in intron 26 was significantly associated with TPP as compared to GD and normal controls (p , 0.001). The identification of the associated SNPs may enable detection of carriers who may be predisposed to TPP.-
dc.languageeng-
dc.publisherMary Ann Liebert, Inc Publishers. The Journal's web site is located at http://www.liebertpub.com/thy-
dc.relation.ispartofThyroid-
dc.rightsThyroid. Copyright © Mary Ann Liebert, Inc Publishers.-
dc.rightsFinal publication is available from Mary Ann Liebert, Inc., publishers http://dx.doi.org/[insert DOI]-
dc.titleAssociation of novel single-nucleotide polymorphisms in the dihydropyridine sensitive L-type Alpha-3 Calcium Channel (CACNL1 α 3) and Thyrotoxic Periodic Paralysis (TPP)-
dc.title.alternativeAssociation of novel single-nucleotide polymorphisms in the dihydropyridine sensitive L-type alpha-3 calcium channel (CACNL1 alpha 3) and thyrotoxic periodic paralysis (TPP)-
dc.typeConference_Paper-
dc.identifier.emailKung, AWC: awckung@hku.hk-
dc.identifier.emailLau, KS: kslau@hku.hk-
dc.identifier.emailChan, VNY: vnychana@hku.hk-
dc.identifier.authorityKung, AWC=rp00368-
dc.identifier.authorityChan, VNY=rp00320-
dc.identifier.hkuros87825-
dc.identifier.volume13-
dc.identifier.issue7-
dc.identifier.spage672, program no. 6-
dc.identifier.epage672, program no. 6-
dc.publisher.placeUnited States-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats